Navigation Links
HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
Date:10/11/2010

STORMONT, BELFAST, Northern Ireland, Oct. 11 /PRNewswire/ -- HeartSine Technologies, Inc. was honored with the Belfast Ambassador Award at the sixth annual Belfast Business Top 50 event in Stormont, Belfast. The award was presented to the company by the Belfast Media Group for pioneering business in developing areas of Belfast, Ireland.

HeartSine CEO Greg Cash, who accepted the award at the Long Gallery in Stormont on behalf of HeartSine, said, "We are honored to be singled out for the Belfast Ambassador Award.  HeartSine has a rich history of innovation and public awareness, especially in the area of Sudden Cardiac Arrest (SCA). We are proud of the work we've done in Northern Ireland, and all around the world."

Cash took the opportunity to share information about SCA and encouraged the attendees to consider starting a Public Access Defibrillator program in their respective organizations. SCA does not discriminate. It can happen anywhere, to anyone, at any time and accounts for an estimated 425,000 deaths in the United States each year, more than the total death rate for breast cancer, lung cancer, and HIV/AIDS combined. The annual mortality rate from SCA throughout Europe and North America exceeds one million. When a defibrillator is used within the first three to five minutes after the onset of SCA, the victim's chance of survival improves 40 to 75 percent.

The 50 companies recognized at the ceremony represented a diverse range of business leaders and entrepreneurs from the Belfast area. Each has worked tirelessly in their individual fields to progress and develop their businesses, despite the economic challenges.

HeartSine's European headquarters is located at 203 Airport Road West, Belfast, Northern Ireland BT3 9ED. For more information, contact +44 (0) 28 9093 9400, info@heartsine.co.uk.

About HeartSine Technologies (www.heartsine.com)

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. Its HeartSine® samaritan® PAD Public Access Defibrillator is especially designed for rescuers of all skill levels to administer lifesaving treatment for Sudden Cardiac Arrest. Sophisticated and lightweight, it's ideal for sports facilities, schools, churches and businesses. Additional information:  info@heartsine.com; (866) 478-7463, ext. 112.


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
2. HeartSine Technologies Supports Living for Zachary Benefit Golf Tournament
3. HeartSine Technologies Supports Run For Sarah Benefit Event
4. Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs
5. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
6. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
7. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
8. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
9. DiFUSION Technologies Adds Accomplished Senior Management Team
10. DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
11. medSage Technologies Introduces Revolutionary Universal CPAP Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
Breaking Medicine Technology:
(Date:1/21/2017)... , ... January 21, 2017 , ... Caronlab Australia, an ... the January ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding ... the quality of its beauty and wellness products. At this trade show, the company ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats in China, ... owner and founder. As Oat is recognized globally as one of the healthiest cereals, ... he believes it is a move to sow the seed of good karma. Buddhism ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern ... has recently joined their multi-specialty medical group. The dermatology practice provides general ... , “We’re excited to add this excellent dermatology practice to our group’s medical ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ ... Holtzclaw in media for its creos™ line of bone regenerative products. Specifically, ... in which he utilizes creos™ allo.gain™ bone graft for a variety of bone ...
(Date:1/20/2017)... ... 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh has posted ... world. Yisrayl says this generation is a time like no other and society needs to ... , Yisrayl says he does not want to sound like an old bible beater because ...
Breaking Medicine News(10 mins):